Physician
Internal Medicine
Dr. Dirk A. Thye, MD
Dirk A. Thye works in the field of Internal Medicine. Dirk A. Thye is a published physician. He published 14 publications, including: 'Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells.'
Publications
- Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infections.
- The isolation of a fibroblast growth inhibitor associated with perigraft seroma.
- Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells.
- Pharmacodynamics of ?-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of ?-lactamases.
- Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
- FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
- FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
- Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
- CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure in...
- CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure inf...
- Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxon...
- Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus...
- Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
Schools
University of California At Los Angeles
Doctors Specialties
- Internal Medicine
Accepted Insurances
Helpful Reviews
Similar Doctors
|
Dr. Peter P. Lee, MD |
|
|
Dr. James E. Forster, MD |
|
|
Dr. Martin M. Mass, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Noble, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Portier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam P. Siegel, MD |
|
|
Dr. Jim Y. Savage, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mandar A. Aras, MD |
|
|
Dr. Bliss M. Temple, MD |
|
|
Dr. Ira D. Goldfine, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|